Polynsatured fatty acids (PUFAs) are organic acids, essential for mammals, whose deficiency is associated with different disesaes. On the basis of currently available evidence, the American Heart Association (AHA) has recommended that all adults eat fish at least twice a week, as well as vegetables containing plant-derived n-3 fatty acids. The AHA also suggests that patients with documentated coronary heart disease consume approximately 1 g of iecosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) per day, from oily fish or fish oil capsules. However, recent evidence broadens their potential application to many other health disorders directly or indirectictly associated with cardiovascular disesase risk such as rheumatological diseases, mood depression, chronic kidney disease, chronic inflammtory lung diseases and others. These effects seem to be largely dependent on the dosages employed and on the characteristics of the selected patients. The cardiometabolic effects of PUFAs have been largely reviewed elsewhere, so the aim of our review is to point out the potential usefulness of such drugs with pleiotropic effects in the management of the actual typical aging patient, with co-morbidities and multidrug therapies.

Cicero A.F.G., Borghi C., Del Corso F., Vinereanu D. (2012). n-3 Polynsatured fatty acids and the patient at high cardiovascular risk with co-morbidities: a pleiotropic drug. CARDIOLOGY AND CLINICAL PRACTICE, 4(1), 1-12.

n-3 Polynsatured fatty acids and the patient at high cardiovascular risk with co-morbidities: a pleiotropic drug.

CICERO, ARRIGO FRANCESCO GIUSEPPE;BORGHI, CLAUDIO;
2012

Abstract

Polynsatured fatty acids (PUFAs) are organic acids, essential for mammals, whose deficiency is associated with different disesaes. On the basis of currently available evidence, the American Heart Association (AHA) has recommended that all adults eat fish at least twice a week, as well as vegetables containing plant-derived n-3 fatty acids. The AHA also suggests that patients with documentated coronary heart disease consume approximately 1 g of iecosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) per day, from oily fish or fish oil capsules. However, recent evidence broadens their potential application to many other health disorders directly or indirectictly associated with cardiovascular disesase risk such as rheumatological diseases, mood depression, chronic kidney disease, chronic inflammtory lung diseases and others. These effects seem to be largely dependent on the dosages employed and on the characteristics of the selected patients. The cardiometabolic effects of PUFAs have been largely reviewed elsewhere, so the aim of our review is to point out the potential usefulness of such drugs with pleiotropic effects in the management of the actual typical aging patient, with co-morbidities and multidrug therapies.
2012
Cicero A.F.G., Borghi C., Del Corso F., Vinereanu D. (2012). n-3 Polynsatured fatty acids and the patient at high cardiovascular risk with co-morbidities: a pleiotropic drug. CARDIOLOGY AND CLINICAL PRACTICE, 4(1), 1-12.
Cicero A.F.G.; Borghi C.; Del Corso F.; Vinereanu D.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/124167
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact